These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1194 related articles for article (PubMed ID: 24161419)
1. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study. Distler M; Pilarsky E; Kersting S; Grützmann R Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma. Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094 [TBL] [Abstract][Full Text] [Related]
3. Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma. Kim J; Lee YS; Hwang IK; Kang BK; Cho JY; Yoon YS; Han HS; Hwang JH J Korean Med Sci; 2015 Mar; 30(3):259-63. PubMed ID: 25729247 [TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
5. Predictive Early Recurrence Factors of Preoperative Clinicophysiological Findings in Pancreatic Cancer. Suzuki S; Shimoda M; Shimazaki J; Maruyama T; Oshiro Y; Nishida K; Sahara Y; Nagakawa Y; Tsuchida A Eur Surg Res; 2018; 59(5-6):329-338. PubMed ID: 30453288 [TBL] [Abstract][Full Text] [Related]
6. Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer. Louhimo J; Alfthan H; Stenman UH; Haglund C Oncology; 2004; 66(2):126-31. PubMed ID: 15138364 [TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability. Shi HJ; Jin C; Fu DL World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110 [TBL] [Abstract][Full Text] [Related]
8. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Hata S; Sakamoto Y; Yamamoto Y; Nara S; Esaki M; Shimada K; Kosuge T Ann Surg Oncol; 2012 Feb; 19(2):636-41. PubMed ID: 21863360 [TBL] [Abstract][Full Text] [Related]
11. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601 [TBL] [Abstract][Full Text] [Related]
12. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102 [TBL] [Abstract][Full Text] [Related]
13. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma. Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702 [TBL] [Abstract][Full Text] [Related]
14. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409 [TBL] [Abstract][Full Text] [Related]
15. Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. Kanda M; Fujii T; Takami H; Suenaga M; Inokawa Y; Yamada S; Nakayama G; Sugimoto H; Koike M; Nomoto S; Kodera Y Surg Today; 2014 Sep; 44(9):1692-701. PubMed ID: 24114022 [TBL] [Abstract][Full Text] [Related]
16. Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis. van Manen L; Groen JV; Putter H; Vahrmeijer AL; Swijnenburg RJ; Bonsing BA; Mieog JSD Biomarkers; 2020 Mar; 25(2):186-193. PubMed ID: 32009482 [No Abstract] [Full Text] [Related]
17. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568 [TBL] [Abstract][Full Text] [Related]
18. Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China. Liao R; Yang J; Zhou BY; Li DW; Huang P; Luo SQ; Du CY World J Surg Oncol; 2015 Jun; 13():196. PubMed ID: 26048469 [TBL] [Abstract][Full Text] [Related]
19. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172 [TBL] [Abstract][Full Text] [Related]
20. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma. Nakagawa S; Yamashita YI; Umezaki N; Yamao T; Okabe H; Imai K; Nitta H; Hashimoto D; Chikamoto A; Baba H Pancreas; 2018 Oct; 47(9):1130-1134. PubMed ID: 30161074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]